Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes
BMC Pregnancy and Childbirth · 2023
DOI: 10.1186/s12884-023-05943-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Pregnancy and Childbirth, 2023. Verfasst von Zhanhui Ou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Boai Hospital of Zhongshan Affiliated to Southern Medical University, 6 Chenggui Road, East District, Zhongshan, 528400…. Hauptthemen laut MEDLINE: Follicle Stimulating Hormone, Follicle Stimulating Hormone, Human. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Research Fund of Guangdong province, Leading Talent in Science and Technology Innovation of Zhongshan.
Abstract (Originalsprache)
Objective
To determine whether a reduced dose of follicle-stimulating hormone (FSH) before human chorionic gonadotropin (hCG) trigger during ovarian stimulation can affect in vitro fertilization (IVF) outcomes.
Methods
This study included 347 patients with a normal ovarian response who received a reduced dose of FSH before hCG trigger for 2–3 days (Group A) and 671 patients who did not receive a reduced dose (Group B) from a university-affiliated IVF center between January 2021 and December 2022. The primary endpoint was estrogen (E2) and progesterone (P) levels on the day of hCG trigger, fresh embryo transfer cycles, laboratory outcomes, and clinical outcomes between the two groups.
Results
On the day of hCG trigger, Group A had significantly lower E2 and P levels than those in Group B (3454.95 ± 1708.14 pg/mL versus 3798.70 ± 1774.26 pg/mL, p = 0.003; and 1.23 ± 0.53 ng/mL versus 1.37 ± 0.59 ng/mL, p < 0.001, respectively). The proportion of patients with P levels ≥ 1.5 ng/mL was 22.48% in Group A compared to 34.58% in Group B (p < 0.001), while the proportion of patients with E2 ≥ 5000 pg/mL was 15.27% in Group A compared to 25.93% in Group B (p < 0.001). The fresh embryo-transfer cycle rate in Group A was higher than that in group B (54.47% and 32.64%, respectively; p < 0.001). Despite the reduction in FSH dosage, there were no significant differences between groups regarding the number of oocytes retrieved, total number of mature oocytes, normal fertilization rate, cleavage rate, Day 3 top-quality rate, implantation rate, pregnancy rate per cycle, and early pregnancy loss rate.
Conclusion
While a reduced dose of FSH prior to hCG trigger during ovarian stimulation did not significantly affect IVF outcomes, it was associated with lower E2 and P levels, resulting in fewer cycles with E2 ≥ 5000 pg/mL and P ≥ 1.5 ng/mL on the day of the hCG trigger.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Reproductive Medicine Center, Boai Hospital of Zhongshan Affiliated to Southern Medical University, 6 Chenggui Road, East District, Zhongshan, 528400, Guangdong, China. Zhanhui-ou@hotmail.com.
- Reproductive Medicine Center, Boai Hospital of Zhongshan Affiliated to Southern Medical University, 6 Chenggui Road, East District, Zhongshan, 528400, Guangdong, China.
- Reproductive Medicine Center, Boai Hospital of Zhongshan Affiliated to Southern Medical University, 6 Chenggui Road, East District, Zhongshan, 528400, Guangdong, China. zsboai2014@163.com.
- The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China. zsboai2014@163.com.
Förderung
- Medical Science and Technology Research Fund of Guangdong province
- Leading Talent in Science and Technology Innovation of Zhongshan
Zitieren
APA
Ou, Z., Du, J., Liu, N., Li, J., & Lin, X. (2023). Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-023-05943-5
Vancouver
Ou Z, Du J, Liu N, Li J, Lin X. Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes. BMC Pregnancy and Childbirth. 2023. doi:10.1186/s12884-023-05943-5
BibTeX
@article{Ou2023,
author = {Ou, Zhanhui and Du, Jing and Liu, Nengqing and Li, Jieliang and Lin, Xiufeng},
title = {Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes},
journal = {BMC Pregnancy and Childbirth},
year = {2023},
doi = {10.1186/s12884-023-05943-5}
}
EUVIMED